Herbalife Cash Flow Statement
NYSE: HLFHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Herbalife free cash flow
In fiscal 2025, Herbalife generated $333.3 million of operating cash flow and spent $80.4 million on capital expenditures. That left free cash flow of $252.9 million, a free-cash-flow margin of 5.0% of revenue. Free cash flow was up 54.8% from the prior year's $163.4 million.
Herbalife returned $8.2 million to shareholders through share repurchases, equal to 3% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Herbalife cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 227.80M | 254.30M | 142.20M | 321.30M | 447.20M | 372.60M | 311.00M | 296.60M | 213.90M | 260.00M |
| Net Income growth (YoY) | -10.42% | +78.83% | -55.74% | -28.15% | +20.02% | +19.81% | +4.86% | +38.66% | -17.73% | -23.33% |
| Depreciation & Amortization | 121.20M | 121.40M | 113.30M | 115.40M | 107.60M | 100.30M | 97.70M | 100.40M | 99.80M | 98.30M |
| Stock-Based Compensation | 44.10M | 50.00M | 48.00M | 44.40M | 54.10M | 51.00M | 38.60M | 35.50M | 42.10M | 40.20M |
| Change in Working Capital | -10.50M | 4.00M | 23.70M | -91.00M | -161.90M | -88.80M | -54.60M | -63.90M | 49.00M | -99.20M |
| Operating Cash Flow | 333.30M | 285.40M | 357.50M | 352.50M | 460.30M | 628.60M | 457.50M | 648.40M | 590.80M | 367.30M |
| Capital Expenditures | -80.40M | -122.00M | -135.00M | -156.40M | -151.40M | -112.00M | -106.10M | -84.00M | -95.50M | -143.40M |
| Investing Cash Flow | -108.70M | -84.60M | -134.80M | -156.20M | -156.40M | -123.20M | -108.00M | -83.90M | -95.20M | -142.40M |
| Dividends Paid | — | — | — | — | — | — | — | 0 | 0 | 0 |
| Share Repurchases | -8.20M | -8.30M | -11.00M | -146.70M | -1.01B | -923.50M | -16.70M | -750.30M | -844.20M | -13.20M |
| Debt Issued | 724.80M | 1.39B | 215.20M | 564.20M | 671.10M | 31.50M | 0 | 998.10M | 1.27B | 200.00M |
| Debt Repaid | -746.60M | -1.94B | -289.60M | -683.50M | -563.50M | -24.50M | -24.50M | -1.24B | -494.50M | -438.80M |
| Financing Cash Flow | -295.50M | -335.30M | -148.30M | -264.70M | -728.60M | -320.90M | -713.00M | -593.10M | -85.20M | -252.30M |
| Net Change in Cash | -62.80M | -157.40M | 79.20M | -94.10M | -443.60M | 206.50M | -367.50M | -80.50M | 438.60M | -47.50M |
| Free Cash Flow | 252.90M | 163.40M | 222.50M | 196.10M | 308.90M | 516.60M | 351.40M | 564.40M | 495.30M | 223.90M |
This table shows 10 annual periods of Herbalife's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HLF's reporting calendar. What is a cash flow statement?